Skip to main content
. 2019 Oct 22;7:408. doi: 10.3389/fped.2019.00408

Table 1.

Comparison of demographic characteristics, interventions in the first 72 h and morbidity of neonates without IVH and those with IVH.

No IVH (n = 374) Mild IVH (n = 73) Severe IVH (n = 48) p-value
Maternal characteristics, n (%)
Antenatal steroids 320 (85.6) 55 (75.3) 32 (66.6) 0.001
Rupture of membrane >24 h 81 (21.6) 15 (20.5) 8 (16.6) NS*
Chorioamnionitis 63 (16.8) 14 (19.1) 14 (29.1) <0.001
Vaginal delivery 208 (55.6) 49 (67.1) 32 (66.7) 0.08
Neonatal characteristics
Gestational age, mean ± SD (weeks) 26.4 ± 1.5 25.5 ± 1.53 25.5 ± 1.57 <0.001
Birth weight, mean ± SD (g) 893 ± 236 816 ± 227 805 ± 217 0.004
Male, n (%) 192 (51.3) 37 (50.6) 30 (62.5) NS
Small for gestational age, n (%) 48 (12.8) 7 (9.5) 4 (8.3) NS
Multiple gestations, n (%) 103 (27.5) 23 (31.5) 17 (35.4) NS
Apgar score <5 at 5 min, n (%) 71 (18.9) 12 (16.4) 17 (35.4) 0.01
Umbilical cord pH < 7, n (%) 11 (2.9) 2 (2.7) 3 (6.2) 0.03
Delayed cord clamping, n (%) 145 (38.8) 23 (31.5) 14 (29.1) NS
Outborn, n (%) 32 (8.6) 9 (12.3) 9 (18.7) 0.07
Respiratory, n (%)
Respiratory distress syndrome 269 (71.9) 70 (95.8) 47 (97.9) <0.001
Extubated within 72 h 137 (36.6) 25 (34.2) 8 (16.6) 0.02
Extubation failure 27 (7.2) 8 (10.9) 8 (16.6) 0.06
Pneumothorax 16 (4.3) 1 (1.3) 2 (4.1) NS
Inhaled nitric oxide treatment 52 (13.9) 12 (16.4) 14 (29.1) 0.02
Hypocapnea 149 (39.8) 22 (30.1) 24 (50) 0.08
Hypercapnea 113 (30.2) 38 (52) 32 (66.6) <0.001
pCO2 fluctuation 35 (9.4) 13 (17.8) 17 (35.4) <0.001
Cardiovascular, n (%)
Normal saline bolus use 87 (23.2) 39 (53.4) 28 (58.3) <0.001
Inotrope use 35 (9.3) 20 (27.4) 23 (47.9) <0.001
Dopamine 35 (9.3) 14 (19.1) 18 (37.5) <0.001
Dobutamine 32 (8.5) 16 (21.9) 18 (37.5) <0.001
Metabolic, n (%)
Hypoglycemia 124 (33.1) 26 (35.6) 18 (37.5) NS
Hyperglycemia 43 (11.5) 19 (26) 9 (18.7) 0.02
Hypothermia 21 (5.6) 4 (5.4) 5 (10.4) 0.03
Hyperthermia 41 (10.9) 11 (15) 7 (14.5) 0.05
Acidosis 111 (29.6) 39 (53.4) 35 (72.9) <0.001
Alkalosis 21 (5.6) 5 (6.8) 3 (6.2) NS
Bicarbonate/THAM therapy 14 (3.7) 7 (9.5) 12 (25) <0.001
Other, n (%)
Sedation 39 (10.4) 16 (21.9) 26 (54.1) <0.001
Early onset sepsis 6 (1.6) 4 (5.4) 3 (6.2) 0.04
Mortality in first week 10 (2.7) 6 (8.2) 16 (33.3) <0.001
*

NS, not significant.